In the literature PD-L1, expressed on cancer cells or tumour infiltrating immune cells, has emerged as a prognostic factor in GC, but its specific role in EBV-related GC has not yet been described [26,27,28,29,30]. This evidence concerns the gene CD274 and neoplasm.